Thermo Fisher posts quarterly results beat as lab products, biopharma services grow
Published on April 23, 2026.
Thermo Fisher has reported a significant increase in its quarterly revenue of $11.01 billion, surpassing analysts' expectations of $10.85 billion. The company's largest segment, laboratory products and biopharma services, saw a 7% increase in revenue from $6.04 billion, compared to $5.64 billion a year earlier. However, shares of the company fell 3.1% in pre-market trade. The Trump administration has been reducing funding for universities and research bodies that Thermo provides its products and services.
Related Articles
Despite Budget Trim, Staffing Shortfalls, Federal Nuclear Energy Push on Target
Despite budget and staff shortages, the US government is committed to doubling its nuclear capacity to 50,000 units by 2050.
Marmalade District finds new life in Salt Lake City
The Marmalade District in Salt Lake City is gaining momentum with a surge in apartment construction, food, and nightlife, despite affordability concerns and ongoing traffic issues.
Lavender Rose Boutiques - Olney, MD Patch
Lavender Rose Boutiques, a women's-owned small business in Olney, Maryland, delivers timeless, thoughtfully curated fashion with unique pieces sourced from around the world.